The Risks of Wogovi: A Closer Look

This chapter examines the alarming rise in overdose deaths linked to prescription drugs during the COVID-19 pandemic, with a specific focus on the controversial GLP-1 drug Wogovi. It details both the purported cardiovascular benefits and significant health risks associated with Wogovi, including severe side effects like thyroid tumors and acute pancreatitis. The discussion emphasizes the importance of consumer awareness and encourages listeners to critically evaluate the safety and viability of such medications.